Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000996025 | SCV001150455 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | FHL1: BP4 |
Labcorp Genetics |
RCV001492550 | SCV001697164 | likely benign | X-linked myopathy with postural muscle atrophy | 2023-09-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003953407 | SCV004770639 | likely benign | FHL1-related disorder | 2022-03-02 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV001700687 | SCV001921402 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000996025 | SCV001963078 | likely benign | not provided | no assertion criteria provided | clinical testing |